In short. The difference between repairing damage and slowing a process, and why the second is so much harder to demonstrate than the first.
Key points
- A study can measure a change in a biological marker, and that measurement is real.
- Whether the marker predicts how the skin looks is a separate question that most studies in this category do not answer, and it is the one a reader actually cares about.
A longevity claim can be tested with a short series of questions, and the first one does most of the work. What follows from the answer is what kind of evidence the claim would need, and whether that evidence exists.
Question one: finding, or rate
Establish which is being claimed. A change in a finding — a pigment patch, a set of wrinkles, a change in texture — can be photographed before and after and compared over months. A change in a rate would require people followed for years against a comparison group, with an appearance graded consistently. Most claims describe the first and imply the second, and the difference between them is the difference between something that has been measured and something that almost never has.
Question two: what was measured, and how
Where a finding is claimed, the questions are answerable. What was assessed, with what instrument or photograph, over what period, and by whom. An assessment made by someone who knew which treatment the person had received is weaker than one made blind, and a photograph taken without standardised lighting cannot be compared with anything.
A marker is not an appearance
A study can measure a change in a biological marker, and that measurement is real. Whether the marker predicts how the skin looks is a separate question that most studies in this category do not answer, and it is the one a reader actually cares about.
Question three: what is the product, and what is it approved for
Name the product and ask what its approval covers. A sunscreen is regulated for protection against ultraviolet radiation, a topical retinoid for defined skin conditions and in some markets fine lines, a device for a specific endpoint, a supplement for nothing of the kind. Where the answer describes something unrelated to the claim, the claim rests on a category word rather than on an indication.
Question four: what has been left out
The last question is about the sentence rather than the study. Where the horizon has been extended, where a finding has been renamed as ageing, or where a laboratory result has been described in the present tense as though it were an outcome, something has been added that the evidence does not supply. Noticing which of those moves is being made usually settles the claim faster than examining the study.
The questions, in the order that resolves them
- Is this claiming a change in a finding, or in the rate of ageing?
- What was measured, with what, over how long, by whom, and in which product?
- What has been added to the claim that the evidence does not supply?
Applied in order, they resolve most of what a reader will meet in this category.
Frequently asked questions
What is the first thing to establish about a longevity claim?
Whether it is claiming a change in a finding or a change in a rate. A finding can be photographed, treated and compared over months. A rate would need years of follow-up against a control. Most claims describe the first and imply the second, and separating them is the whole exercise.
What kind of study would support a rate claim?
A long follow-up of comparable groups, with exposure and outcome measured consistently and the assessment done by someone who did not know which group was which. It is expensive, slow and hard to design, which is why almost nobody has done it and why the claims continue to be made without it.
How do I check what a product is actually approved for?
Ask what the product is and what its approval covers. A sunscreen is regulated for protection against ultraviolet radiation, a topical retinoid for defined conditions and in some markets fine lines, a device for a specific endpoint. If the answer describes something unrelated to the claim, the claim is resting on a category word rather than on an approval.
Risks & Limitations
- Sun protection has the strongest evidence in the field and almost no downside; almost nothing else in the category does.
- Nothing is approved as a treatment for skin ageing itself, and approvals belong to products and defined endpoints.
- Topical retinoids irritate and require continued use; devices carry burn, pigment change and scarring.
- Supplements, drinks and programmes sold as longevity have no demonstrated effect on how skin ages in people.
- A mechanism is a reason to study something rather than a result, and a treated finding can recur.
When to Seek Care
- A mole or patch that is changing in size, shape or colour — have it assessed by a clinician.
- A lesion that bleeds, itches or will not heal — have it assessed by a clinician.
- Blistering, crusting or pigment change that follows a device treatment — have it assessed by a clinician.
- A rash, or irritation from a topical that does not settle when use is paused, is assessed by a clinician rather than managed indefinitely.
References & Further Reading
- World Health Organization (WHO) — ultraviolet radiation and skin cancer prevention guidance
- U.S. Food and Drug Administration (FDA) — sunscreen and topical product labelling and indications
- National Medical Products Administration (NMPA, China) — approved products and their indications
- Cochrane Library — systematic reviews of topical treatments and photoprotection
- Chinese Medical Association Dermatology Branch — clinical guidance
This page is a review of published evidence and regulation, not medical advice, and it does not cite individual studies. It is not a booking page and it does not recommend a product or treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.